Aarhus University Seal

Dansk

 AU  Collaboration Commercialisation of research Spin-outs

Spin-outs from AU

Spin-outs

What is a spin-out?

  • A spin-out company is a business established based on agreements with the institution (Aarhus University or Region Midtjylland) regarding the transfer of technologies and rights (ownership or licensing rights)
  • A spin-out can also be established based on agreements with a specific inventor to independently exploit a right in exchange for compensation to the institution.

Meet Three Spin-outs

Visblue Visblue was founded in 2015 to commercialize sustainable energy storage with a patented vanadium redox flow battery. The company is based on an invention originating from the Department of Engineering.
Radisurf The company's goal is to develop solutions for bonding different types of materials - for example, plastic and metal - materials that have proven challenging to bond with existing products. In the summer of 2021, the company was sold for 100+ million DKK.
VPCIR biosciences The company's primary product is an inexpensive and rapid method for tracking pathogens. A patent application has been filed for the underlying technology. The company is a spin-out from Aarhus University and The Chinese University of Hong Kong.

Spin-outs from Aarhus University

MedTech & Diagnostics

BioTech & Pharma

Developing small molecule for cancer treatment

 

Deal 2023 | Founded 2023

Developing a research platform used to identify receptors that can bind to pharmaceutical candidates.

 
Deal 2021 | Founded 2021

Has developed methods to genetically engineer the cells.

 
Deal 2020 | Founded 2020

Harnessing the natural machinery of the lysosome.

 

Deal 2017 | Founded 2017

Developing STING modulators to treat severe Systemic lupus erythematosus.

 

Deal 2014 | Founded 2007

Developing chemicals, methods, and patents for biomolecule conjugation.

 
Deal 2010 | Founded 2009

Developing a novel platform technology for prodrug biopharmaceuticals.

 

Deal 2023 | Founded 2023

Developing a first-in-class treatment for infertile women.

 

Deal 2021 | Founded 2021

Harnessing the innate immune system to battle cancer.

 

Deal 2018 | Founded 2018

A new inhalable combination drug for the treatment of invasive aspergillosis in the lungs.

 
Deal 2015 | Founded 2014

Developing oral therapy for Frontotemporal Dementia.

 
Deal 2012 | Founded 2010

Technology to harness the power of the complement system, a vital part of the innate immune system.

 

Deal 2023 | Founded 2023

Treating or preventing neurodegenerative diseases.

 

Deal 2020 | Founded 2020

Novel, efficient bacterial vaccine candidates based on our proprietary platform technology BEMAP.

 
Deal 2018 | Founded 2018

Develops novel therapeutics for neuromuscular diseases.

 

Deal 2014 | Founded 2015

Creating a novel class of anti-fungals to treat serious invasive fungal infections.

 
Deal 2010 | Founded 2009

GreenTech, Materials & Food

Digital Solutions

Revised 11.05.2024